Loading...
OrthoPediatrics Q1 2025 Earnings Report
OrthoPediatrics reported strong first quarter 2025 financial results, with significant revenue growth and improved profitability, and increased its full-year 2025 revenue guidance.
Key Takeaways
OrthoPediatrics delivered a strong first quarter 2025 performance, with total revenue increasing 17% year-over-year to $52.4 million. The company also improved its adjusted EBITDA and reduced free cash flow usage, while expanding its scoliosis portfolio with a new system launch.
Total revenue for Q1 2025 increased 17% to $52.4 million compared to Q1 2024.
Adjusted EBITDA improved to a loss of $0.4 million in Q1 2025 from a loss of $1.1 million in Q1 2024.
Free cash flow usage was reduced by 35% compared to the prior year, with anticipation of positive free cash flow in Q4 2025.
Full year 2025 revenue guidance was increased to $236.0 million to $242.0 million, representing 15% to 18% growth.
OrthoPediatrics
OrthoPediatrics
OrthoPediatrics Revenue by Segment
OrthoPediatrics Revenue by Geographic Location
Revenue by Segment
Trauma & Deformity Revenue
CapyFin.comScoliosis Revenue
CapyFin.comSports Medicine/Other Revenue
CapyFin.comRevenue by Geographic Location
U.S. Revenue
CapyFin.comInternational Revenue
CapyFin.com Forward Guidance
OrthoPediatrics increased its full-year 2025 revenue guidance to $236.0 million to $242.0 million, representing 15% to 18% growth over 2024 revenue. The company reiterated annual set deployment to be $15.0 million and adjusted EBITDA guidance of $15.0 million to $17.0 million.
Positive Outlook
- Increased full year 2025 revenue guidance to $236.0 million to $242.0 million.
- Anticipate first full quarter of positive free cash flow in fourth quarter 2025.
- Reiterated annual set deployment to be $15.0 million.
- Reiterated adjusted EBITDA guidance of $15.0 million to $17.0 million for the full year of 2025.
- Company believes it is well positioned for continued growth in any economic environment due to U.S. manufacturing, supply chain, and non-elective nature of procedures.
Revenue & Expenses
Visualization of income flow from segment revenue to net income